Showing results (1501-1510 of 1,565) with videos related to

Sort By:
Pageof 157
Nature Communications|March 14, 2024
Inter-species gene flow drives ongoing evolution of Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilisOuli Xie, Jacqueline M Morris, Andrew J Hayes, et al.
Biophysical Journal|July 28, 2026
Meso-soup: A Community Approach to Building a Computational Description of the Biological MesoscaleSarah Anne Harris, Gianluca Lattanzi, Angelo Rosa, et al.
Elife|March 2, 2021
Genomic epidemiology of COVID-19 in care homes in the east of EnglandWilliam L Hamilton, Gerry Tonkin-Hill, Emily R Smith, et al.
Nature|October 26, 2001
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18J Parkhill, G Dougan, K D James, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitorsAmanda C Guidon, Leeann B Burton, Bart K Chwalisz, et al.
Science (New York, N.Y.)|November 11, 2017
Genomic history of the seventh pandemic of cholera in AfricaFrançois-Xavier Weill, Daryl Domman, Elisabeth Njamkepo, et al.
Nature Cancer|April 26, 2021
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerKatherine L Morel, Anjali V Sheahan, Deborah L Burkhart, et al.
Journal for Immunotherapy of Cancer|January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term respondersBrandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2007
Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolonesTran Thuy Chau, James Ian Campbell, Claudia M Galindo, et al.
Pageof 157